SCHEMBL6167058

SCHEMBL6167058

CC1(C)CCC(=O)c2c(-c3ccccc3)nn(-c3ccc(Cl)nn3)c21

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.41
CCNA2 P20248 1/20 0.41
CDK2 P24941 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ALDH1A1 P00352 3/20 0.36
NPSR1 Q6W5P4 1/20 0.34
HTT P42858 2/20 0.33
CYP1A2 P05177 1/20 0.33
GAA P10253 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
LMNA P02545 2/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
SRC P12931 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6166406 0.90 CCNA2 (0.41) KDM4ECCNA2CDK2RAB9ASMN1; SMN2
SCHEMBL6166604 0.87 CCNA2 (0.39) KDM4ECCNA2CDK2RAB9ASMN1; SMN2
SCHEMBL6162683 0.86 CCNA2 (0.38) KDM4ECCNA2CDK2RAB9ASMN1; SMN2
SCHEMBL6166539 0.86 SRC (0.39) KDM4ECCNA2CDK2RAB9ASMN1; SMN2
SCHEMBL6164575 0.84 CCNA2 (0.38) KDM4ECCNA2CDK2RAB9ASMN1; SMN2
SCHEMBL6167233 0.83 CDK2 (0.39) KDM4ECCNA2CDK2RAB9ASMN1; SMN2
SCHEMBL6164065 0.82 SMN1; SMN2 (0.44) KDM4ECCNA2CDK2RAB9ASMN1; SMN2
SCHEMBL6167448 0.81 CYP1A2 (0.39) KDM4ECCNA2CDK2RAB9ASMN1; SMN2
SCHEMBL6163631 0.81 CCNA2 (0.39) KDM4ECCNA2CDK2RAB9ASMN1; SMN2
SCHEMBL6185430 0.80 CCNA2 (0.43) CCNA2CDK2RAB9ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed